Exozymes (EXOZ) Retained Earnings (2023 - 2026)
Exozymes (EXOZ) posted quarterly Retained Earnings of $24.5 million for Q4 2025, up 305.11% year-over-year from $6.0 million in Q4 2024, and up 232.8% quarter-over-quarter from -$18.4 million in Q3 2025.
Exozymes (EXOZ) Retained Earnings (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Retained Earnings for 3 consecutive years, with $24.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings rose 305.11% year-over-year to $24.5 million; the TTM figure through Dec 2025 stood at $24.5 million (up 305.11% YoY), while the FY2025 annual figure was $24.5 million, up 305.11% from the prior year.
- Retained Earnings grew to $24.5 million in Q4 2025 per EXOZ's latest filing, from -$18.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $24.5 million in Q4 2025 and bottomed at -$18.4 million in Q3 2025.
- Historically, Retained Earnings has averaged $5.8 million across 3 years, with a median of $6.5 million in 2024.
- On a YoY basis, Retained Earnings climbed as much as 305.11% in 2025 and fell as far as 383.46% in 2025.
- Exozymes' Retained Earnings stood at -$6.1 million in 2023, then sank by 96.33% to -$11.9 million in 2024, then jumped by 305.11% to $24.5 million in 2025.
- Business Quant data shows EXOZ's Retained Earnings at $24.5 million in Q4 2025, -$18.4 million in Q3 2025, and $23.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 4.38 Bn |
| 10 | Exozymes | 62.92 Mn | 62.92 Mn | - | 30.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.01 Mn |
| Dec 31, 2025 | 24.50 Mn |
| Sep 30, 2025 | -18.45 Mn |
| Jun 30, 2025 | 23.40 Mn |
| Mar 31, 2025 | 22.68 Mn |
| Dec 31, 2024 | -11.95 Mn |
| Sep 30, 2024 | 6.51 Mn |
| Dec 31, 2023 | -6.08 Mn |